Tools chosen: kalshi_direct claude_news congress_bills polymarket_related kalshi_related gdelt_news wikipedia code_execution

Sub-questions (Fermi decomposition)

Planner reasoning

This is a long-horizon Kalshi political market on a formal US-China free trade agreement becoming law before Jan 20, 2029. The bar is very high: not just a trade 'deal' or truce, but Senate ratification or Congressional-Executive Agreement with implementing legislation. Key research is the current market anchor, status of US-China trade negotiations, whether any pending deal is structured as a formal FTA requiring Congress, and historical base rates for FTA negotiation-to-ratification timelines.

# Current state No formal free trade agreement negotiation with China exists; current US-China engagement (Busan truce Oct 2025, Beijing summit May 2026) consists of executive-level tariff truces and purchase pledges, not a treaty or congressional-implementing-legislation process. Kalshi prices this at 19% YES, having fallen from a 30-day high after the underwhelming May 2026 Beijing summit. # Timeline of key events - 2020-01-15: Phase One trade deal signed — executive agreement, not congressionally ratified FTA (USTR, confirmed). - 2025 (spring–): US-China tariff talks widen but produce no comprehensive agreement (congress.gov CRS, confirmed). - 2025-10 (Busan, S. Korea): Trump-Xi reach tariff truce/economic deal — exclusion extensions, rare earth/soybean purchase pledges; framed by White House as "massive victory," not a treaty (whitehouse.gov, confirmed). - 2025-11: USTR extends certain tariff exclusions one year (congress.gov CRS, confirmed). - 2025-12: USTR deems PRC mature-node chip/SiC practices "actionable," defers action w/ 0% tariff until June 2027 (congress.gov CRS, confirmed). - China soybean purchases materially underdeliver vs. pledge (1.4M tons vs. 25M ton/yr pledge) (American Action Forum, confirmed). - 2026-05 (Beijing summit): Trump-Xi meet two days; analysts describe "modest" outcomes, low expectations, no formal treaty (Al Jazeera, confirmed). - China frames arrangements as administrative "Board of Trade" tariff/market-access mechanism, not a treaty (China Briefing, confirmed). - No FTA or implementing legislation ever introduced in Congress as of research date (congress_bills search, confirmed — no matching bills found). # Event Will a US-China free trade agreement become law (via Senate ratification or Congressional-Executive Agreement + implementing legislation) before Jan 20, 2029? # Outcomes to forecast Yes / No # Kalshi market anchor **19.00% YES** (KXFTAPRC-29). 7-day change: +3pts; 30-day change: -10pts. Price range over 56 days: 14%-40% (peak likely tied to truce/summit headline news, since faded). Avg daily volume: 115 contracts — thin but active. # Sub-question answers 1. **Status/framing of negotiations** — Current deals (Busan Oct 2025, Beijing May 2026) are executive-level truces/purchase pledges, explicitly not framed as comprehensive FTAs; China itself calls it a "Board of Trade" tariff/market-access arrangement (China Briefing, claude_news). 2. **Congressional legislation/appetite** — No FTA or implementing legislation has been introduced (congress_bills search returned zero matches). Bipartisan China hawkishness suggests low ratification appetite even if a deal were signed (code_execution Fermi analysis). 3. **Historical FTA timelines** — NAFTA ~2.5yr, USMCA ~2yr (with 25-yr template), KORUS ~5yr signing-to-ratification, TPP never ratified after 5.5yr. With zero existing US-China FTA framework and no negotiations launched, the 4-year window is compatible only under the most optimistic historical analog (code_execution). 4. **Trump administration posture** — Continued tariff actions, Section 301 "actionable" findings, extended exclusions point to managed adversarial trade relationship, not decoupling-reversal via treaty (congress.gov CRS IF12125). 5. **Market pricing** — Kalshi: 19% YES, trending down 30-day (-10pts) despite a recent bounce (+3pts, 7-day). No Polymarket equivalent market exists (0 matches found). A related "enact FTA (any country)" Kalshi market (KXFTA-29) prices 39%, implying China-specific odds are seen as far lower than a generic FTA. 6. **Headline risk (false-YES triggers)** — Busan truce and Beijing summit are exactly the kind of announcements traders might mistake for FTA progress, but neither involves treaty language, Senate ratification, or implementing legislation — both would NOT resolve YES. # Key facts (high-confidence, factual) 1. [congress_bills] Zero FTA-related bills or implementing legislation found in Congress for US-China trade. 2. [USTR] Phase One (2020) was an executive agreement, establishing precedent that even prior "wins" don't reach FTA/ratification status. 3. [China Briefing/whitehouse.gov] 2025-2026 deals are truces/purchase pledges/Board of Trade mechanisms, not treaties. 4. [trade.gov] US-China don't even have a Bilateral Investment Treaty (last negotiated 2016) — a much lower bar than an FTA. 5. [congress.gov CRS] Continued Section 301 tariff actions into Dec 2025 show adversarial trade posture continuing alongside truce talks. # Cross-market signals - Kalshi related: KXFTA-29 (any-country FTA) prices 39% — more than double China-specific market, suggesting market sees China as a uniquely hard case. - Kalshi related: CHINAUSGDP-30 (China overtakes US economy) at 17%, KXCHINAEUV (China EUV access) at 11% — general China-related Kalshi markets cluster in low-to-mid teens/20s. - Polymarket: No matching markets found (0/100 scanned). - Sportsbook implied: N/A (not applicable to this event type). # Analyst opinions and speculation - Al Jazeera (May 2026): analysts had "low expectations" for Beijing summit producing any breakthrough. - code_execution Fermi model: multiplicative sequential probability (launch negotiations × reach signed deal × Congress ratifies) ≈0.15%, scenario-weighted ≈0.85%, final judgmental estimate ~1-2%, well below current Kalshi price of 19%. - American Action Forum: prior "handshake deal" purchase pledges have already underdelivered, casting doubt on durability/seriousness of even informal commitments. # Directional lean per outcome - **Yes**: Some support from Trump's demonstrated willingness for high-profile "dealmaker" summits (Busan, Beijing) and repeated public claims of "massive victories"; possibility of a loosely-labeled "Phase Two" deal getting rebranded as FTA-like. Opposing: no negotiations launched toward comprehensive FTA, no legislation introduced, bipartisan hawkish Congress, non-market-economy/IP/subsidy disputes unresolved, only 4 years available vs. 2-5+ year historical norms starting from zero framework. - **No**: Strongly favored — structural evidence (no bills, no BIT, executive-only deals, adversarial tariff actions continuing) overwhelmingly points to No. This aligns directionally with Kalshi's declining 30-day trend. # Gaps / unknowns - No visibility into any confidential negotiation tracks beyond public truce announcements. - Unclear how strictly "FTA" would be interpreted if a broader deal is signed and unilaterally mislabeled by either side. - No Polymarket cross-check available for this specific event. # Calibration anchors - Kalshi current YES price (anchor): **19%**. - Quantitative/Fermi model estimate: **~1-2%**, substantially below market price — suggesting Kalshi may be overpricing YES, possibly due to residual optimism from truce/summit headlines. - Historical precedent: no full-cycle US FTA has ever completed in under 2 years even with existing frameworks (USMCA); zero precedent for FTA with a strategic-rival non-market economy.

1. Both forecasts land between the Kalshi price (19%) and the Fermi model (~1-2%), but neither explains why they didn't weight the Fermi/structural evidence more heavily given it's described as "well below current Kalshi price" with detailed multiplicative reasoning (negotiations launched × deal signed × ratified ≈0.15%-0.85%) — both converge on 6-10% seemingly by splitting the difference rather than justifying why the market's 19% deserves that much residual weight. 2. Neither forecaster engages with the cross-market signal that KXFTA-29 (any-country FTA) prices at 39% while China-specific prices at 19%, which could be used to sanity-check whether 19% itself is already a "discounted" China-specific price rather than an inflated headline-driven one — this comparison is ignored in both rationales. 3. Both cite "ambiguity in resolution" (rebranded Phase Two deal counted as FTA-like) as a reason to keep YES above the Fermi estimate, but the brief explicitly states Busan/Beijing "would NOT resolve YES" under the sub-question's strict definition (Senate ratification or CEA+implementing legislation) — this suggests the resolution-ambiguity upweighting may be a reference-class/rules error rather than genuine tail risk. 4. Neither forecast addresses the specific historical base rate that "no full-cycle US FTA has ever completed in under 2 years even with existing frameworks" combined with zero existing BIT/framework with China — this is arguably the single strongest piece of evidence and deserves more explicit weight than a passing mention of "2-5+ years." 5. Both forecasts assign similar confidence (0.65, 0.74) despite reaching different point estimates (10% vs 6%) — given the evidence brief's own model outputs cluster around 1-2%, a forecaster with high confidence should more decisively resolve whether they trust market-anchoring or the Fermi model, rather than blending both without a clear rationale for the blend weights. 6. Neither considers tail-risk scenarios in the other direction, e.g., a second-term Trump administration bypassing Congress via a purely executive "Phase Three" arrangement that markets or resolution sources might loosely credit as an "FTA" for headline/political purposes, which could keep YES resolution risk non-negligible even without formal ratification — this ambiguity in real-world resolution/adjudication is underexplored on both sides.

5% (70% confidence)

Yes: 5% No: 95%

The strict resolution criteria (Senate ratification or CEA plus implementing legislation) combined with zero launched negotiations, zero bills in Congress, no existing BIT framework, and continued Section 301 actions make YES structurally near-impossible within the remaining ~2.7 years — no US FTA has ever completed in under 2 years even with an existing framework. The Fermi decomposition (~1-2%) is more credible than the Kalshi 19% anchor, which appears inflated by truce/summit headlines that explicitly would not resolve YES, and the market's -10pt 30-day fade supports this reading. The critique correctly notes both forecasters over-weighted resolution ambiguity given the brief's clear ruling that executive truces don't count, justifying a pull below both forecasts. I retain ~5% YES only for the genuine unknowns: confidential negotiation tracks, possible lenient adjudication of a rebranded 'Phase Two/Three' deal, and the long remaining horizon.

Total pipeline time: 182.9s